Lauren Barnes Joins Ossium Health’s Board of Directors
Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow banking platform, today announced the appointment of Lauren Barnes to its Board of Directors.
- Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow banking platform, today announced the appointment of Lauren Barnes to its Board of Directors.
- “Lauren’s expertise and proven track record in biopharmaceutical commercialization are invaluable assets,” said Kevin Caldwell, Ossium’s CEO, Co-Founder & President.
- In addition, Barnes serves as a board member for Ascelia Pharma AB, a Swedish oncology drug development company with two late-stage drug candidates, and she recently completed her time as Chair of the Board of Directors for the non-profit Cancer Support Community.
- “I am incredibly excited to join Ossium’s Board of Directors at this pivotal moment in the company’s journey,” said Barnes.